RNASEH2C
Ribonuclease H2 subunit C
Also known as: AGS3, AYP1, RNH2C_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TDP1
- Gene
- RNASEH2C
- Ensembl
- ENSG00000172922
- Chromosome
- 11
- Canonical length
- 164 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a ribonuclease H subunit that can cleave ribonucleotides from RNA:DNA duplexes. Mutations in this gene cause Aicardi-Goutieres syndrome-3, a disease that causes severe neurologic dysfunction. A pseudogene for this gene has been identified on chromosome Y, near the sex determining region Y (SRY) gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
164 residues, UniProt reviewed canonical sequence.
>Q8TDP1|RNASEH2C
1 MESGDEAAIE RHRVHLRSAT LRDAVPATLH LLPCEVAVDG PAPVGRFFTP AIRQGPEGLE
61 VSFRGRCLRG EEVAVPPGLV GYVMVTEEKK VSMGKPDPLR DSGTDDQEEE PLERDFDRFI
121 GATANFSRFT LWGLETIPGP DAKVRGALTW PSLAAAIHAQ VPEDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RNASEH2C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 43 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 43 nTPM
- colon: 25 nTPM
- prostate: 23 nTPM
- pituitary gland: 22 nTPM
- ovary: 22 nTPM
- cervix: 22 nTPM
Single-cell type
- syncytiotrophoblasts: 250 nCPM
- late spermatids: 231 nCPM
- decidual stromal cells: 197 nCPM
- gastric progenitor cells: 162 nCPM
- plasma cells: 157 nCPM
- hofbauer cells: 156 nCPM
Immune cell
- plasmacytoid DC: 23 nTPM
- classical monocyte: 15 nTPM
- naive B-cell: 13 nTPM
- memory B-cell: 13 nTPM
- NK-cell: 11 nTPM
- intermediate monocyte: 11 nTPM
Brain region
- white matter: 18 nTPM
- cerebellum: 17 nTPM
- cerebral cortex: 16 nTPM
- choroid plexus: 16 nTPM
- basal ganglia: 16 nTPM
- pons: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RNASEH2C.
Disease | AllUniProt
Conditions RNASEH2C is implicated in, by any mechanism.
- Aicardi-Goutieres syndrome 3 (AGS3) MIM:610329
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 414 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Aicardi-Goutieres syndrome 3
- Aicardi Goutieres syndrome
- Abnormality of the nervous system
- RNASEH2C-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.47
- gnomAD pLI
- 0.01
- gnomAD missense Z
- -0.92
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ribonuclease H2, subunit C
- Ribonuclease H2 subunit C
- Ribonuclease H2 non-catalytic subunit (Ylr154p-like)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RNASEH2C in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RNASEH2C as an antibody target. Whether an autoantibody or antibody against RNASEH2C could matter depends on whether native RNASEH2C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RNASEH2C is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RNASEH2C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...